Van der Straeten Charis, Ockier Noor, Verbeke Jolien, Van Hecke Ineke, Bettens Kim, Van Lierde Kristiane
Department of Rehabilitation Sciences, Center for Speech and Language Sciences (CESLAS), Ghent University, Ghent, Belgium.
Department of Speech-Language Pathology and Audiology, University of Pretoria, Pretoria, South Africa.
J Oral Rehabil. 2025 Jul;52(7):1070-1082. doi: 10.1111/joor.13974. Epub 2025 May 14.
Orofacial Myofunctional Therapy (OMT) is a widely adopted behavioural intervention for managing Orofacial Myofunctional Disorders (OMDs). Nevertheless, there is a lack of data on the long-term outcomes of OMT.
The aim of this study was to compare orofacial myofunctional status, orofacial strength, and Oral Health-Related Quality of Life (OHRQoL) in healthy adults with and without a history of OMT, and to explore person- and therapy-related factors influencing long-term outcomes of OMT.
Thirty-one healthy adults (mean age 23.9 years old, SD 3.99 years) who underwent OMT as a child or adolescent were included in this cross-sectional study (OMT group), as well as 31 age and gender matched control participants without a history of OMT (non-OMT group). For perceptual assessment of orofacial functions, the Orofacial Myofunctional Evaluation with Scores (OMES) was used, with higher scores indicative of better performance. Maximum isometric pressure and endurance measurements were obtained using the Iowa Oral Performance Instrument (IOPI). The Oral Health Impact Profile questionnaire (OHIP-NL14) was used to assess OHRQoL.
The OMT group did not show significant differences in orofacial appearance/posture, mobility, strength, endurance, or OHRQoL compared to those who did not undergo therapy. The OMT group did demonstrate a significantly higher OMES function sub score (p = 0.046) and exhibited a typical swallowing pattern significantly more frequently (p = 0.045) than the non-OMT group. No demographic or therapy-related factors significantly influencing long-term OMT intervention outcomes were identified.
These results suggest that OMT may have a lasting positive impact in the treatment of OMDs, indicating its effectiveness over the long term.
口面部肌功能治疗(OMT)是一种广泛应用于管理口面部肌功能障碍(OMD)的行为干预方法。然而,关于OMT长期疗效的数据却很匮乏。
本研究旨在比较有和没有OMT治疗史的健康成年人的口面部肌功能状态、口面部力量以及与口腔健康相关的生活质量(OHRQoL),并探讨影响OMT长期疗效的个人因素和治疗相关因素。
本横断面研究纳入了31名在儿童或青少年时期接受过OMT治疗的健康成年人(平均年龄23.9岁,标准差3.99岁)(OMT组),以及31名年龄和性别匹配且无OMT治疗史的对照参与者(非OMT组)。对于口面部功能的感知评估,使用了带评分的口面部肌功能评估(OMES),分数越高表明表现越好。使用爱荷华口腔功能仪器(IOPI)获得最大等长压力和耐力测量值。使用口腔健康影响概况问卷(OHIP-NL14)评估OHRQoL。
与未接受治疗的人相比,OMT组在口面部外观/姿势、活动度、力量、耐力或OHRQoL方面没有显著差异。OMT组的OMES功能子评分显著更高(p = 0.046),并且比非OMT组更频繁地表现出典型的吞咽模式(p = 0.045)。未发现显著影响OMT长期干预效果的人口统计学或治疗相关因素。
这些结果表明,OMT可能对OMD的治疗具有持久的积极影响,表明其长期有效性。